Over a period of 10 years, the group that received the placebo had an 89% survival rate without the disease, while the group that received beta-carotene had a 92% survival rate (25)
This is possibly due to the immature antioxidant system and membrane repair mechanisms of the oocyte
Abstract Cardiovascular disease (CVD) remains the leading cause of death in patients with type 2 diabetes (T2D)
Depending on the dose, either metformin or Ozempic may lower blood sugar levels more than the other drug
Now that there is no longer a semaglutide shortage, compounded semaglutide wont be legally available after May 2025
Therefore, the Food and Drug Administration (FDA) released a guidance requiring all new drugs for glycemic control in T2DM patients to demonstrate cardiovascular safety, a policy that was continued and further emphasized in the 2020 FDA Guidance for Diabetes Drug Development [7, 8]